Thiel-Behnke corneal dystrophy
Thiel-Behnke corneal dystrophy
Explore linked clinical trials. Standard reference: MONDO:00111851 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Nutritional and Metabolic Diseases, Thiel-Behnke corneal dystrophy, amyloidosis, corneal disorder, corneal dystrophy, eye disorder, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT07750678 |